Dr. Jason Byron Thompson, MD

Dr. Thompson practices at ENHABIT HOSPICE BIRMINGHAM in Pell City, Alabama.

Dr. Thompson's NPI, 1740236694, was assigned on May 25, 2006. Dr. Thompson holds Alabama license 25087.

Dr. Thompson's primary practice is ENHABIT HOSPICE BIRMINGHAM, at 74 Plaza Dr Ste 1c, Pell City, AL 35125.

Dr. Thompson's primary practice is ENHABIT HOSPICE BIRMINGHAM in Pell City, Alabama. Dr. Thompson is also affiliated with UAB St. Vincent’s St. Clair. The medical group on file is Birmingham Heart Clinic. Dmand AI also links Dr. Thompson to 2 more hospitals, 2 group practices and clinics and 2 medical groups, each named with a free account. Dr. Thompson's employer is on file too: a hospice.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Thompson practices, 6 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Thompson's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Thompson is licensed in Alabama.

CMS data shows 4,427 Medicare services from Dr. Thompson across 36 procedure codes in 2024, for 855 Medicare patients. Medicare paid $280,930 for them.

CMS counts 855 Medicare patients who saw Dr. Thompson in 2024. The largest group is 75 to 84, with 358 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Thompson's median patient age at 70, with 55% women.

In 2024, Dr. Thompson wrote 8,166 Medicare Part D claims for 1,114 patients. 83% of them were for generic drugs. CMS names the drug for 7,771 of them, across 88 drugs with 11 or more claims each, at $1,336,960 in total drug cost. In 2023, CMS named 7,289 claims across 87 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Thompson for performance year 2024, reported as part of a group. Dr. Thompson accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Thompson as offering telehealth. CMS counts 47 procedures of varicose vein removal by Dr. Thompson, more than 73% of the clinicians it reports for that procedure.

Coronary angioplasty and stenting: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Thompson in 2015. Dr. Thompson's most frequent co-author is Tom L. Delbanco, MD.

Dmand AI links Dr. Thompson to 1 clinical trial. Conditions studied include Peripheral Arterial Disease and Peripheral Vascular Diseases.

CMS Open Payments shows 445 general payments to Dr. Thompson from 38 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 93% of the total. Novo Nordisk Inc paid the most, $229,657.